9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Initial combination therapy with metformin and colesevelam safely achieves glycemic and lipid goals in early Type 2 Diabetes Endocrine Practice
2. 2010 Colesevelam HCl to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study. Endocrine Practice
3. 2010 Insulin Action Textbook of Diabetes, 4th edition. Eds: Holt RIG, Goldstein B, Flyvbjerg A, Cockram CS. Wiley-Blackwell
4. 2010 The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: The Sea Islands genetic African American registry (project SuGAR). Journal of Lipid Research, 51:586-597
5. 2010 Mammalian Tribbles Homolog 3 Impairs Insulin Action in Skeletal Muscle: Role in Glucose-Induced Insulin Resistance. American Journal of Physiology, 298:E565-E576
6. 2010 Adiponectin and the metabolic syndrome: mechanisms mediating the risk of metabolic and cardiovascular disease Current Opinion in Lipidology
7. 2010 Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 59:791-799
8. 2010 Insulin Action Textbook of Diabetes, 4th edition. Eds: Holt RIG, Goldstein B, Flyvbjerg A, Cockram CS. Wiley-Blackwell
9. 2010 A Diabetes-Specific Enteral Formula Improves Glycemic Variability in Patients with Type 2 Diabetes. Diabetes Technology and Therapeutics, 12:419-425
10. 2009 Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58:2498-2505
11. 2009 Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid {beta}-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women. Journal of Nutrition 139:1073-1081
12. 2009 A qualitative assessment of educational opportunities for primary care providers in Type 2 Diabetes Care. Diabetes Spectrum 22 (4):248-253
13. 2009 Role of Nutrition in the Pathophysiology, Prevention, and Treatment of Type 2 Diabetes and the Spectrum of Cardiometabolic Disease Fourth Edition of Preventive Nutrition
14. 2009 The Power of Fat. commentary Cell Science Reviews 5
15. 2009 Role of Nutrition in the Pathophysiology, Prevention, and Treatment of Type 2 Diabetes and the Spectrum of Cardiometabolic Disease Fourth Edition of Preventive Nutrition, Eds. Bendich A and Deckelbaum R. Humana and Springer, New York NY
16. 2009 A genome-wide linkage scan in Gullah speaking African American families with Type 2 Diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). Diabetes 58:260-267
17. 2009 Adiponectin Reduces Lipid Accumulation by in Macrophage Foam Cells. Atherosclerosis, 202:152-161
18. 2009 The Power of Fat.commentary Cell Science Reviews 5:75-82
19. 2009 Helicobacter pylori Infection and Inflammation: Implications for Pathophysiology of Diabetes Mellitus and Coronary Heart Disease. Journal of Life Sciences 1:45-50
20. 2008 Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocrine Practice 14:933-946
21. 2008 The Diagnosis and management of Pre-Diabetes in the Continuum of Hyperglycemia – When do the risks of diabetes begin. Endocrine Practice
22. 2008 Effects of short-term very low calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism, 57:1-8
23. 2008 Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia Journal of Psychiatric Research, 42:1076-1085
24. 2008 Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes. Nutrition, 24:990-997
25. 2008 Entero-insular axis and postprandial insulin differences in African American and European American children. American Journal of Clinical Nutrition, 88:1277-1283
26. 2008 Adiponectin Multimers and Metabolic Syndrome Traits: Relative Ad Resistance in African-Americans. Obesity, 16:2616-2623
27. 2008 Risk Factors related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and their Relationship with Nephropathy and Macrovascular Complications. Diabetes Care, 31:2006-2012
28. 2008 Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome. Endocrinology and Metabolism Clinics of North America 37:841-856
29. 2008 Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort Journal of Diabetes and Its Complications, 22:153-163
30. 2007 Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and anti-lipolysis. Neuropsychopharmacology
31. 2007 Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health & Place, 13:179-187
32. 2007 Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis. 190:359-369
33. 2007 Adiponectin and the metabolic syndrome: mechanisms mediating the risk of metabolic and cardiovascular disease. Current Opinion in Lipidology, 18:263-270
34. 2007 The Effect of Insulin on Expression of Genes and Biochemical Pathways in Human Skeletal Muscle. Endocrine, 31:5-17
35. 2007 NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System: Potential Role in Insulin Resistance Journal of Biological Chemistry, 282:31525-31533
36. 2007 Insulin’s actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease. J Am Soc Hyperten, 1:414-422
37. 2006 UCP3 and Human Metabolism Journal of Clinical Endocrinology and Metabolism, 91:1226-1228
38. 2006 Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry. 45:1128-1137
39. 2006 Adiponectin multimeric complexes and the Diabetes, 55:249-259
40. 2006 A polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in non-diabetic women. Diabetes, 55:3630-3634
41. 2006 Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and MMP expression in advanced atherosclerotic plaques. Journal of Cardiovascular Pharmacology, 48:212-222
42. 2006 Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-medial thickness.  Diabetic Medicine, 23:955-966
43. 2005 Mitochondrial DNA (mtDNA) Haplotypes Reveal Maternal Population Affinities of Sea Island Gullah‑speaking African Americans. American Journal of Physical Anthropology, 127:427-438
44. 2005 Mitochondrial DNA Genetic Diversity among Four Ethnic Groups in Sierra Leone American Journal of Physical Anthropology, 128:156-163
45. 2005 Adiponectin Promotes Adipocyte Differentiation, Insulin Sensitivity, and Lipid Accumulation: Potential Role in Auto-Regulation of Adipocyte Metabolism and Adipose Mass. Journal of Lipid Research, 46:1369-1379
46. 2005 Nutritional Therapy for the Metabolic Syndrome The Handbook of Clinical Nutrition, 4th Edition. Eds. D. Heimburger, J Ard. Mosby-Year Book, Inc., St. Louis
47. 2005 Metabolic Syndrome and Diets Healthy Aging. 1(4):25-26
48. 2005 Apolipoprotein C-III Protein Concentrations and Gene Polymorphisms in Type 1 Diabetes: Associations with Microvascular Disease Complications in the DCCT/EDIC Cohort. Journal of Diabetes and its Complications, 19:18-25
49. 2004 Individual differences in the response to ingested nutrients. Nutrition. 20:1
50. 2004 Mechanisms of Insulin Signal Transduction International Textbook of Diabetes, 3rd Edition. Eds. R.A. DeFronzo, E. Ferrannini, H. Keen, P. Zimmet. John Wiley & Sons, Ltd. London
51. 2004 Nutrigenomics Special Issue of Nutrition, Volume 20, Issue 1, Pages 1-172
52. 2004 Type 2 Diabetes Mellitus Encyclopedia of Endocrine Diseases. Ed. L. Martini. Academic Press/Elsevier Science (USA), Burlington, MA, USA
53. 2004 Role of UCP2 and UCP3 in nutrition and obesity. Nutrition, 20:139-144
54. 2004 Diet, Insulin Resistance, and Obesity: Zoning in on Data for Atkins Dieters Living in South Beach. Journal of Clinical Endocrinology and Metabolism, 89:4197-4205
55. 2004 Critical Evaluation of ATP III criteria in identifying insulin resistance with dyslipidemia Diabetes Care,27:978-983
56. 2004 Estimation of Resting Energy Expenditure Considering Diabetes Care, 27:1405-1411
57. 2004 Facilitative Glucose Transporter Gene Expression in Human Lymphocytes, Monocytes, and Macrophages: a Role for GLUT Isoforms 1, 3, and 5 in the Immune Response and Foam Cell Formation Blood Cells, Molecules, & Diseases, 32:182-190
58. 2004 Diabetic retinopathy and serum lipoprotein in the DCCT/EDIC Cohort Investigative Ophthalmology and Visual Science, 45:910-918
59. 2003 Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African Americans. Human Biology, 75:147-161
60. 2003 Apolipoprotein C-III Protein Concentrations and Gene Polymorphisms in Type 1 Diabetes: Associations with Lipoprotein Subclasses. Metabolism, 53:1296-1304
61. 2003 Dietary sodium modulation of insulin action and gene expression in adipocytes
62. 2003 Lipoprotein Abnormalities in Type 1 Diabetes". Current Opinion in Endocrinology and Diabetes. Lippincott Williams & Wilkins, London, UK. 10(4):245-250
63. 2003 Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with Gender and Glycemia. Diabetes Care, 26:810-818
64. 2003 The Effects of Insulin Resistance and Type 2 Diabetes Mellitus on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance. Diabetes, 52:453-462
65. 2003 The Search for Obesity Genes in Isolated Populations: Gullah-Speaking African Americans and the Role of Uncoupling Protein 3 as a Thrifty Gene. Progress in Obesity Research: 9. Eds: G. Medeiros-Neto, A. Halpern, C. Bouchard. John Libbey Eurotext Ltd. 9:373-380
66. 2003 Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: associations with Diabetic Nephropathy. Kidney International, 64:817-828
67. 2003 Fibrinogen is a marker for nephropathy and peripheral vascular disease in Type 1 Diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care, 26:1439-1448
68. 2003 Plasma Prekallikrein: a Risk Marker for Hypertension and Nephropathy in Type 1 Diabetes. Diabetes, 52:1215-1221
69. 2003 The role of uncoupling protein 3 in human physiology Journal of Clinical Investigation, 111:438-441
70. 2002 The Adipocyte Lipid Binding Protein (ALBP/aP2) Gene Facilitates Foam Cell Formation in Human THP-1 Macrophages. Atherosclerosis, 165:259-269
71. 2002 Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes, 51:2895-2902
72. 2002 Troglitazone is an Effective Therapeutic Agent in Patients with Glucocorticoid-induced Diabetes. Diabetes Research and Clinical Practice, 58:87-96
73. 2001 Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. American Journal of Physical Anthropology. 114:18-29
74. 2001 Adipocytes express abnormalities in translocation and trafficking of vesicles containing GLUT4 and insulin-regulated aminopeptidase in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 86:5450-5456
75. 2001 A role for the agouti related protein promoter in obesity and type 2 diabetes. Biochemical Biophysical Research Communications, 287:568-573
76. 2000 Reduced plasma leptin concentrations in Bulimia nervosa. Brewerton, T.D., Lesem, M.D., Kennedy, A., Garvey, W.T.
77. 2000 Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethnicity and Disease.
78. 2000 Treatment of Diabetes Mellitus in Adults Conn’s Current Therapy. Ed. R.E. Rakel. W.B. Saunders Company. Philadelphia, Year 2000 edition, pp 546-566, 2000
79. 1999 Aberrant DNA sequence pattern caused by a heterozygosity. BioTechniques. 26:604-606
80. 1999 Endogenous mutations in human uncoupling protein 3 alter its functional properties FEBS Letters, 464:189-193
81. 1999 Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology. 140:1151-1157
82. 1999 Dual energy x-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome Diabetes Care. 22:1310-1317
83. 1999 A novel missense mutation R70W in the human uncoupling protein 3 gene in a family with type 2 diabetes. Human Mutation. 13:506
84. 1998 Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. American Journal of Medicine. 105:331-345
85. 1998 Diabetes research in South Carolina: past, present, and future. Journal of the South Carolina Medical Association. 94:502-508
86. 1998 The Insulin Resistance Syndrome. 1.                  In: clinicalCORNERSTONE--Diabetes Mellitus. Ed. Garvey, W.T. Excerpta Medica, Inc., New York. Volume 1 (3), 1998.
87. 1998 Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes: 47:1935-1940
88. 1998 Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. Journal of Clinical Investigation. 102:1345-1351
89. 1998 Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. Journal of Clinical Investigation. 101:2377-2386
90. 1998 Transmission of two novel mutations in a pedigree with familial lecithin: cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband Journal of Lipid Research, 39:1870-187
91. 1998 Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in caucasian and african-american subjects. . Diabetes. 47:685-687
92. 1998 Cloning of Rab GTPase isoforms expressed in human skeletal muscle: Studies in insulin resistant subjects Hormone and Metabolic Research, 30:656-662
93. 1998 Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. American Journal of Human Genetics, 62:659-668
94. 1998 An autosomal genomic scan for loci linked to pre-diabetic phenotypes in Pima Indians. Journal of Clinical Investigation, 101:1757-1764
95. 1998 An autosomal genomic scan for loci linked to type II diabetes mellitus and body mass index in Pima Indians: an obesity-diabetes locus at 11q23-25 American Journal of Human Genetics: 63:1130-1138
96. 1997 Genome wide search for genes influencing percent body fat in Pima Indians: Suggestive linkage at chromosome 11q22 American Journal of Human Genetics. 60:166-173
97. 1997 Gestational diabetes mellitus and gene mutations which affect insulin secretion. Diabetes Research and Clinical Practice. 36:135-141
98. 1997 Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians. Journal of Cellular Biochemistry. 65:527-541
99. 1997 The Insulin Resistance Syndrome. On the Cutting Edge (a publication of the DCE practice group of the American Dietetic Association). Ed. K.A. O'Keefe. 18:6-9
100. 1997 The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Journal of Clinical Endocrinology and Metabolism. 82:1293-1300
101. 1997 Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition Diabetes. 46:444-450
102. 1997 Exercise in transgenic mice hyperexpressing GLUT4 glucose transporters: Effects on substrate metabolism and glycogen regulation Metabolism, 46:1349-1357
103. 1996 The expression of TNFa by human muscle: Relationship to insulin resistance. . The Journal of Clinical Investigation. 97:1111-1116
104. 1996 . Isolation by preparative free-flow electrophoresis and aqueous two-phase partitioning from rat adipocytes of an insulin-responsive small vesicle fraction with glucose transport activity. The Journal of Chromatography. 680:201-212
105. 1995 The effects of Brefeldin A on the glucose transport system in rat adipocytes: Implications regarding the intracellular locus of insulin-sensitive GLUT4. The Journal of Biological Chemisty, 270:30199-30204
106. 1995 Mechanisms of enhanced insulin sensitivity in endurance-trained athletes. Journal of Clinical Endocrinology and Metabolism, 80:2437-2446
107. 1995 Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle: Implications for glucose toxicity. Journal of Clinical Investigation, 96:2792-2801
108. 1994 Biologic actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes: Chronic ability to increase glycogen synthase activity. Diabetes. 43:53-63
109. 1994 Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. American Journal of Physiology. 266:F283-F290
110. 1994 Gene expression of epithelial glucose transporters: The role of diabetes mellitus. Journal of the American Society of Nephrology, 5:S29-S36
111. 1994 GLUT 4 glucose transporters and insulin action in humans: regulation at the level of gene expression and cellular trafficking Molecular Biology of Diabetes. Eds. B. Draznin, and D. LeRoith, The Humana Press Inc., Totowa NJ, vol. II, p 437-471
112. 1994 Glucose transporter proteins and insulin sensitivity in humans Brazilian Journal of Medical and Biological Research, 27:933-939
113. 1994 Cellular insulin action and insulin resistance Bailliere's Clinical Endocrinology and Metabolism: Insulin Resistance and Disease. Ed. E. Ferrannini, Bailliere Tindall, London, 7:785-873
114. 1993 Insulin responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles Journal of Clinical Endocrinology and Metabolism. 77:286-289
115. 1993 Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT 4 glucose transporters Diabetes. 42:1773-1785
116. 1993 Potential role of insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in rat adipocytes. Endocrinology. 133:2943-2950
117. 1993 Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic and insulin-treated diabetic rats Metabolism. 42:1310-1315
118. 1993 Effects of diabetes on the myocardial glucose transport system in rats: Implications for diabetic cardiomyopathy American Journal of Physiology.
119. 1992 Gene expression of GLUT 4 glucose transporters in skeletal muscle from insulin-resistant patients with obesity, impaired glucose tolerance, gestational diabetes, and non-insulin-dependent diabetes mellitus Diabetes. 41:465-475
120. 1992 The glucose transporters of rat renal proximal tubule: Differential expression and subcellular localization American Journal of Physiology. 262:F807-F812
121. 1992 Glucose transport and non-insulin dependent diabetes mellitus. Diabetes Care (Review Issue) 15:396-417
122. 1991 Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity Endocrinology. 128-2415-2426
123. 1991 Glucose and insulin regulate insulin action via different mechanisms in BC3H-1 myocytes: Effects on glucose transporter gene expression Diabetes. 41:274-285
124. 1991 Immunological crossreactivity and inverse regulation with the vitamin D receptor Proceedings of the National Academy of Sciences, USA. 88:8347-8351
125. 1991 New insights into the metabolic regulation of insulin action and insulin resistance: Role of glucose and amino acids FASEB Journal. 5:3031-3036
126. 1991 Pretranslational suppression of a glucose transporter protein causes cellular insulin resistance in non-insulin-dependent diabetes mellitus and obesity. Journal of Clinical Investigation. 87:1072-1081
127. 1989 Mechanisms of insulin resistance in obese Type II diabetic subjects Diabetes Mellitus: Pathophysiology and Therapy. Bayer AG Centenary Symposium. Eds. Creutzfeldt, W. and Lefebvre, P., Spinger-Verlag, Berlin, pp. 107-126
128. 1989 Insulin resistance non-insulin-dependent diabetes mellitus: Which horse is pulling cart? Diabetes/Metabolism Reviews. Ed. R. DeFronzo, John Wiley and Sons, New York, 5:727-742
129. 1989 Studies of the insulin receptor kinase and glucose transport systems of Diabetes, Nutrition, and Metabolism. 1:344-362
130. 1989 Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology. 125-2341-2349
131. 1989 Suppression of an insulin-responsive glucose transporter gene in diabetes mellitus Science. 125-2341-2349
132. 1989 Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: Dexamethasone decreases transporter mRNA in primary cultured adipocytes . Molecular Endocrinology. 3:1132-1141
133. 1989 Dexamethasone regulates the glucose transport system in primary cultured adipocytes: Different mechanisms of insulin resistance following acute and chronic exposure. Endocrinology. 124:2063-2073
134. 1989 Characterization of glucose uptake in primary cultured neurons Journal of Neuroscience Research. 22:397-407
135. 1989 Cellular and molecular pathogenesis of insulin resistance Insulin Action: volume II Molecular and Cellular Biology of Diabetes Mellitus. Eds. B. Draznin, S. Melmed, and D. LeRoith, Alan R. Liss, Inc., New York, pp. 79-95
136. 1989 Glucose and insulin chronically regulate the glucose transport system. Elsevier Science Publishers, Amsterdam, pp. 341-344
137. 1988 Correlations between in vivo and in vitro actions of insulin in obesity and diabetes Diabetes/Metabolism Reviews. Ed. R. DeFronzo, John Wiley and Sons, New York pp. 44:543-570
138. 1988 Pathogenesis and cellular mechanisms of insulin resistance in Type II non-insulin-dependent diabetes mellitus Pathogenesis of Non-Insulin-Dependent Diabetes Mellitus. Ed. Grill, W., Raven Press, New York, pp. 171-200
139. 1988 Day-long integrated serum insulin and C-peptide profiles in patients with Type II diabetes mellitus: Correlation with urinary C-peptide excretion Diabetes. 37:590-599
140. 1988 The role of glucose transporters in the cellular insulin resistance of Type II non-insulin-dependent diabetes mellitus Journal of Clinical Investigation.
141. 1988 Cellular mechanisms of insulin resistance in non-insulin dependent (Type II) diabetes mellitus. American Journal of Medicine. 85 (Suppl. 5A): 86-105
142. 1987 Impact of Insulin Resistance and Generalized Adiposity on Intramyocellular Lipid: Differential Relationships in European and African Americans. None
143. 1987 -chromosome haplotypes show closer genetic distance to Sierra Leoneans and reduced European American admixture in Gullah-speaking African Americans. None
144. 1987 Genes and Biochemical Pathways in Human Skeletal Muscle Affecting Resting Energy Expenditure and Fuel Partitioning. None
145. 1987 Radiography and magnetic resonance imaging in lipoatrophic diabetes Skeletal Radiology. 15:179-180 and 16:320-323
146. 1987 Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes: A new mechanism of insulin resistance. Journal of Biological Chemistry. 262:189-197
147. 1987 Glucose transporters: Overview and implications for the brain. Insulin, Insulin-Like Growth Factors, and their Receptors in the Central Nervous System. Eds. M.K. Raizada, M.I. Phillips, and D. Leroith, Plenum Press, New York, pp. 71-92
148. 1987 Human adipocyte glucose transport system: Biochemical and functional heterogeneity of hexose carriers Journal of Clinical Investigation. 79:703-709
149. 1987 Shunting of insulin from a retroendocytotic pathway to a degradative pathway by sodium vanadate Journal of Biological Chemistry. 262:12005-12012
150. 1987 Xanthogranulomatosis in an adult of American Academy of Dermatology. 16:183-187
151. 1987 Dietary adherence during weight loss predicts weight regain. None
152. 1987 Associations of adiponectin with retinopathy in the DCCT/EDIC cohort: influence of insulin resistance None
153. 1985 Overexpression of resistin induces insulin resistance and stimulates production of proinflammatory cytokines in 3T3-L1 cells. Nutrition and Metabolism, 3:28
154. 1985 Plasma leptin, ASP/C3adesARG, and Adiponectin in lean normotensive and metabolic syndrome subjects at baseline and during acute hyperlipidemia None
155. 1985 Modulation of insulin secretion by insulin and glucose in Type II diabetes mellitus Journal of Clinical Endocrinology and Metabolism 60:559-568
156. 1985 Insulin resistance in non-insulin-dependent (Type II) and insulin dependent (Type I) diabetes mellitus. Adv. Exp. Med. Biol., Plenum Press, New York, pp. 189:176-205
157. 1985 The effect of insulin treatment on insulin secretion and insulin action in Type II diabetes mellitus Diabetes 34:222-234
158. 1985 Multiple endocrinopathies in an infant with fatal neurodegenerative disease. Shankar, R.R., A. Haider, W.T. Garvey, and G.R. Freidenberg
159. 1985 A biallelic variant in the uncoupling protein 2 gene: correlation with percent body fat in African-Americans and functional studies in yeast None
160. 1985 Insulin induces insulin resistance in cultured rat adipocytes: Sequential effects at receptor and multiple postreceptor sites Diabetes. 35:258-267
161. 1984 The syndrome of limited joint mobility (SLJM) in diabetes None
162. 1984 . Primary culture of isolated adipocytes Journal of Biological Chemistry 259:6376-6384
163. 1978 Insulin receptor downregulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes Non
164. 1978 In vitro vitamin-K-dependent conversion of precursor to prothrombin in chick liver Journal of Nutrition 108:1078-1086


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.